Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes ceiling...

    NPPA fixes ceiling price of painkiller, tetanus injections; Details

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-30T11:00:49+05:30  |  Updated On 30 Jun 2019 11:00 AM IST
    NPPA fixes ceiling price of painkiller, tetanus injections; Details

    New Delhi: Through a recent notification, the drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of three drug formulations namely, Ibuprofen Capsule 200mg, Tetanus Toxoid (0.5ML) and Tetanus Toxoid (5ML) under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST)


    Ibuprofen was discovered in 1961 by Stewart Adams and initially marketed as Brufen. It is available under a number of trade names, including Advil and Motrin.


    The drug is indicated for treating pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby.


    Presently, the ceiling price of the drug as decided by NPPA reads;



























    Sl. No.Name of the Scheduled

    Formulation
    Dosage form & StrengthUnitCeiling Price

    (Rs.)
    (1)(2)(3)(4)(5)
    1.IbuprofenCapsule 200mg1 soft gelatin Capsule2.62

    Further, the prices of Tetanus Toxoid injections have been fixed by NPPA following the directions given by the Department of Pharmaceuticals (DoP) while allowing the review petition filed by Biological E Limited. Medical Dialogues had earlier reported that in its decision, DoP had ordered NPPA to refix the ceiling prices of the vaccine on merit, separately for 0.5 ml ampoules and 5ml vials.


    Tetanus Toxoid Vaccine is given to provide protection (immunity) against tetanus (lockjaw)in adults and children 7 years or older.


    Also Read: Refix Ceiling Price of Tetanus Toxoid Vaccine: DoP directs NPPA


    The details of the refixed ceiling price of the same as fixed by the NPPA reads;


























































    Sl.

    No.
    Name of the Scheduled FormulationDosage form & StrengthUnitCeiling Price (Rs.)Review Order number and dateExisting SO number and date
    (1)(2)(3)(4)(5)(6)(7)
    1.Tetanus ToxoidInjectionEach Pack (0.5ML)10.6131015/46/2018-

    Pricing dated
    1485(E) dated 29.03.2019
    19.03.2019(at Sl. No. 795)
    2.Tetanus ToxoidInjectionEach Pack22.9431015/46/2018-1485(E) dated
    (5ML)Pricing dated 19.03.201929.03.2019

    (at Sl. No. 796)

    Also Read: NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    AdvilarthritisBrufenceiling priceDOPibuprofeninjectionsmenstrual periodsMigraineMotrinNational Pharmaceutical Pricing AuthorityNPPApharmapharma newspharma news indiaTetanus injectionTetanus Toxoid

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok